  Domain experts often rely on most recent knowledge for apprehending and
disseminating specific biological processes that help them design strategies
for developing prevention and therapeutic decision-making in various disease
scenarios. A challenging scenarios for artificial intelligence (AI) is using
biomedical data (e.g., texts, imaging, omics, and clinical) to provide
diagnosis and treatment recommendations for cancerous conditions.~Data and
knowledge about biomedical entities like cancer, drugs, genes, proteins, and
their mechanism is spread across structured (knowledge bases (KBs)) and
unstructured (e.g., scientific articles) sources. A large-scale knowledge graph
(KG) can be constructed by integrating and extracting facts about semantically
interrelated entities and relations. Such a KG not only allows exploration and
question answering (QA) but also enables domain experts to deduce new
knowledge. However, exploring and querying large-scale KGs is tedious for
non-domain users due to their lack of understanding of the data assets and
semantic technologies. In this paper, we develop a domain KG to leverage
cancer-specific biomarker discovery and interactive QA. For this, we
constructed a domain ontology called OncoNet Ontology (ONO), which enables
semantic reasoning for validating gene-disease (different types of cancer)
relations. The KG is further enriched by harmonizing the ONO, metadata,
controlled vocabularies, and biomedical concepts from scientific articles by
employing BioBERT- and SciBERT-based information extractors. Further, since the
biomedical domain is evolving, where new findings often replace old ones,
without having access to up-to-date scientific findings, there is a high chance
an AI system exhibits concept drift while providing diagnosis and treatment.
Therefore, we fine-tune the KG using large language models (LLMs) based on more
recent articles and KBs.
